Loading...
Loading...
Application UK00909986175 · Registered
| Application Number | UK00909986175 |
| Status | Registered |
| Owner | Eli Lilly and Company |
| Filed | 2011-05-23 |
| Registered | 2011-12-20 |
| Renewal Due | 2031-05-23 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. VERZENIOS is currently a registered UK trademark, with renewal due on 2031-05-23. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; pharmaceutical preparations for use in the treatment and prevention of anxiety spectrum disorders, atherosclerosis and Alzheimer's; pharmaceutical preparations for use in the treatment and prevention of diabetes; pharmaceutical preparations for use in the treatment and prevention of rheumatoid arthritis; pharmaceutical preparations for use in the treatment and prevention of Crohn's disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment and prevention of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment and prevention of autoimmune disorders; Veterinary preparations for companion animals in the treatment and prevention of weight loss, obesity, urine spraying, chronic pain, gastrointestinal disorders, neurodegenerative disorders, parasitic infestations, neurological disorders, anxiety, hypertension, dermatitis, cancer, anemia associated with chronic renal failure, fleas, pain associated with orthopedic and soft tissue surgery, chronic kidney disease, and emesis; preparations for destroying vermin, namely, insecticides for use with livestock and livestock premises; veterinary preparations for the treatment, control and symptomatic relief of infectious and metabolic diseases of livestock; medicated dietary food supplements for animals; antibacterial pharmaceuticals; production enhancement products for livestock, namely, medicated feed and medicated water additives; medicated feed additives and medicated water additives for animals; diagnostic agents, preparations, and substances to identify pathogens or residues of biological interest for veterinary use; pharmaceutical preparations; veterinary preparations.
'VERZENIOS' is a registered trademark on the UK IPO register, owned by Eli Lilly and Company. The application (UK00909986175) was filed on 23 May 2011 and registered on 20 December 2011. The registration is set to expire on 23 May 2031.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Page, White & Farrer Limited.
UK trademark UK00909986175 for the mark 'VERZENIOS' in Class 5 is recorded on the UK IPO register as owned by Eli Lilly and Company. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00909986175 for the mark 'VERZENIOS' as registered.
UK trademark UK00909986175 for the mark 'VERZENIOS' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, end…
UK trademark UK00909986175 for the mark 'VERZENIOS' was filed at the UK IPO on 23 May 2011 and registered on 20 December 2011.
UK trademark UK00909986175 for the mark 'VERZENIOS' is currently recorded as valid until 23 May 2031, at which point it will need to be renewed with the UK IPO to remain in force.
Page, White & Farrer Limited is listed as the attorney / representative of record for UK trademark UK00909986175 for the mark 'VERZENIOS' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "VERZENIOS" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| VERZENIOS CONTINUOUS CARESame applicant | 87299090 | 606 | 2017-01-12 |
| VERZENIOS CONTINUOUSCARESame applicant | 87201083 | 606 | 2016-10-12 |
| VERZENIOSSame applicant | 86711380 | 606 | 2015-07-31 |
| VERZENIOSSame applicant | 86278596 | 606 | 2014-05-12 |
| VERZENIOSSame applicant | 85183669 | 606 | 2010-11-23 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| VERZENIOSSame applicant | 1426553 | protected | 2011-05-20 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.